Literature DB >> 6471778

Elevated plasma fibronectin levels in nephrotic syndrome.

J Zazgornik, W Graninger, E Minar, P Schmidt, P Balcke, A Haubenstock, H Kopsa.   

Abstract

In nine patients with nephrotic syndrome the behaviour of plasma fibronectin was studied. Of nine patients seven showed elevated plasma fibronectin levels while the plasma fibrinogen level was increased in eight of the nine investigated patients. A positive correlation was found between plasma fibronectin levels and fibrinogen (P less than 0.01), cholesterol (P less than 0.01) and proteinuria (P less than 0.05). The results indicate that elevated plasma fibronectin levels could be an additional factor responsible for hypercoagulability in nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6471778     DOI: 10.1007/bf01727747

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  8 in total

Review 1.  Hypercoagulability in the Nephrotic syndrome.

Authors:  K Andrassy; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-10-01

Review 2.  Antithrombin III deficiency and thromboembolism.

Authors:  E Thaler; K Lechner
Journal:  Clin Haematol       Date:  1981-06

3.  Coagulation studies in 45 cases of nephrotic syndrome without uremia.

Authors:  A Kanfer; D Kleinknecht; M Broyer; F Josso
Journal:  Thromb Diath Haemorrh       Date:  1970-12-31

4.  Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases.

Authors:  H D Todd; M S Coffee; T P Waalkes; M D Abeloff; R G Parsons
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

5.  Red blood cell aggregation in nephrotic syndrome.

Authors:  P Ozanne; R B Francis; H J Meiselman
Journal:  Kidney Int       Date:  1983-03       Impact factor: 10.612

6.  On the incidence of renal vein thrombosis in the nephrotic syndrome.

Authors:  F Llach; A Koffler; E Finck; S G Massry
Journal:  Arch Intern Med       Date:  1977-03

7.  Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.

Authors:  R H Kauffmann; J J Veltkamp; N H Van Tilburg; L A Van Es
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

8.  [Fibronectin and other immunologic parameters in chronic polyarthritis].

Authors:  W Siegmeth; E Minar; W Graninger; K Pirich; J Zazgornik
Journal:  Z Rheumatol       Date:  1984 Jan-Feb       Impact factor: 1.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.